Nexstim Oyj
OMXH:NXTMH
Nexstim Oyj
EPS (Diluted)
Nexstim Oyj
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
N
|
Nexstim Oyj
OMXH:NXTMH
|
EPS (Diluted)
€0
|
CAGR 3-Years
41%
|
CAGR 5-Years
62%
|
CAGR 10-Years
N/A
|
|
R
|
Revenio Group Oyj
OMXH:REG1V
|
EPS (Diluted)
€0
|
CAGR 3-Years
2%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
M
|
Modulight Oyj
OMXH:MODU
|
EPS (Diluted)
€0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
B
|
Bioretec Oy
OMXH:BRETEC
|
EPS (Diluted)
€0
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
O
|
Optomed Oyj
OMXH:OPTOMED
|
EPS (Diluted)
€0
|
CAGR 3-Years
3%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
B
|
Biohit Oyj
OMXH:BIOBV
|
EPS (Diluted)
€0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Nexstim Oyj
Glance View
Nexstim Oyj engages in the provision of medical technology products. The company is headquartered in Helsinki, Etela-Suomen and currently employs 37 full-time employees. The company went IPO on 2014-11-14. The company is focused on improving rehabilitation for stroke patients through the use of noninvasive brain stimulation. Its offering comprises: a diagnostic tool for brain surgery planning, Navigated Brain Stimulation (NBS) System, which comprises navigated transcranial magnetic stimulation (nTMS) device for presurgical mapping (PSM) of the motor and speech cortices; and a device for stroke therapy called Navigated Brain Therapy (NBT) System, which focuses stimulation on targeted locations in the brain in order to enhance rehabilitation process. The NBT System targets upper limb motor disability and is under Phase III pivotal clinical trial study at rehabilitation sites in the United States. The Company’s systems are used in over 100 facilities in research, therapy and neurosurgical planning purposes. Nexstim Oyj has two subsidiaries: Nexstim Inc and Nexstim Germany GmbH.
See Also
What is Nexstim Oyj's EPS (Diluted)?
EPS (Diluted)
-0.1
EUR
Based on the financial report for Jun 30, 2024, Nexstim Oyj's EPS (Diluted) amounts to -0.1 EUR.
What is Nexstim Oyj's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
62%
Over the last year, the EPS (Diluted) growth was 76%. The average annual EPS (Diluted) growth rates for Nexstim Oyj have been 41% over the past three years , 62% over the past five years .